74 related articles for article (PubMed ID: 589274)
1. Bromocriptine and uterine neoplasia.
Br Med J; 1977 Dec; 2(6100):1475-6. PubMed ID: 589274
[No Abstract] [Full Text] [Related]
2. [Malignant uterine neoplasms in rats after bromocriptine (Parlodel "Sandoz")].
Setekleiv J; Borchgrevink C
Tidsskr Nor Laegeforen; 1978 Apr; 98(10):525. PubMed ID: 675607
[No Abstract] [Full Text] [Related]
3. Absence of uterine neoplasia in patients on bromocriptine.
Besser GM; Thorner MO; Wass JA; Doniach I; Canti G; Curling M; Grudziniskas JG; Setchell ME
Br Med J; 1977 Oct; 2(6091):868. PubMed ID: 922331
[No Abstract] [Full Text] [Related]
4. Bromocriptine and uterine neoplasia.
Griffith RW
Br Med J; 1977 Dec; 2(6102):1605. PubMed ID: 589369
[No Abstract] [Full Text] [Related]
5. [Role of progesterone in carcinogenesis of the vagina, cervix and endometrium in mice].
Reboud S; Pageaut G
Ann Anat Pathol (Paris); 1972; 17(2):187-98. PubMed ID: 4661325
[No Abstract] [Full Text] [Related]
6. Gynecological follow-up of parkinsonian patients on long-term bromocriptine treatment.
Grönroos M; Salmi T; Erkkola R; Liukko P; Rinne UK
Acta Obstet Gynecol Scand; 1985; 64(1):81-2. PubMed ID: 3976380
[TBL] [Abstract][Full Text] [Related]
7. Induced mesenchymal tumors of the rat genital tract.
Castro HF; Fechner RE; Spjut HJ
Arch Pathol; 1968 Nov; 86(5):475-80. PubMed ID: 5681432
[No Abstract] [Full Text] [Related]
8. [Steroid contraception and cancer (author's transl)].
Andolsek L
Jugosl Ginekol Opstet; 1978; 18(2):193-9. PubMed ID: 755125
[No Abstract] [Full Text] [Related]
9. The DESAD project.
Ariz Med; 1977 Apr; 31(4):260-1. PubMed ID: 849173
[No Abstract] [Full Text] [Related]
10. [Oral contraception and cancers of the uterus and the breast].
Vokaer R
J Gynecol Obstet Biol Reprod (Paris); 1974; 3(3):379-400. PubMed ID: 4470735
[No Abstract] [Full Text] [Related]
11. [Progesterone based cervical-uterine-cancer therapy essay. Clinical, cytological, and histological study. Outcomes.1952].
García G; de Laguna JC; Alvarez Fuentes G
Ginecol Obstet Mex; 2007 Jun; 75(6):364-9. PubMed ID: 18297862
[No Abstract] [Full Text] [Related]
12. Bromocriptine in the management of advanced carcinoma of the cervix.
Emembolu JO; Ekwempu CC
Cent Afr J Med; 1987 May; 33(5):117-9. PubMed ID: 3450400
[No Abstract] [Full Text] [Related]
13. Effective treatment of a patient with an advanced carcinoma of the cervix with a combination of bromocriptine and aprotinin.
Guthrie D; Ross WM; Latner AL; Turner GA; Way S
Br J Clin Pract; 1981 Sep; 35(9):330-2. PubMed ID: 6173053
[No Abstract] [Full Text] [Related]
14. [Does the "pill" promote the development of tumors?].
Lauritzen C
Med Klin; 1980 Aug; 75(16):6-7. PubMed ID: 6251352
[No Abstract] [Full Text] [Related]
15. Experimental and clinical aspects of the carcinogenic potential of steroid contraceptives.
Hertz R
Int J Fertil; 1968; 13(4):273-86. PubMed ID: 4882601
[No Abstract] [Full Text] [Related]
16. [Cancerogenesis of contraceptive pills and lessons learned].
Nau JY
Rev Med Suisse; 2005 Aug; 1(30):1991. PubMed ID: 16200945
[No Abstract] [Full Text] [Related]
17. [Bromocryptine in the treatment of carcinoma of the uterine cervix and its immunomodulating effect].
Presl J
Cesk Gynekol; 1984 Jul; 49(6):453-4. PubMed ID: 6488341
[No Abstract] [Full Text] [Related]
18. Treatment of recurrent carcinoma of the cervix with bromocriptine.
Praest J; Klem V
Br J Obstet Gynaecol; 1986 May; 93(5):519-20. PubMed ID: 3707885
[No Abstract] [Full Text] [Related]
19. Hormonal contraceptives and the risk of cancer.
Holck S
World Health Stat Q; 1987; 40(3):225-32. PubMed ID: 3687058
[No Abstract] [Full Text] [Related]
20. Estrogens and cancer of the female reproductive system.
Boyce JG
Urban Health; 1977 Apr; 6(3):14-5, 56. PubMed ID: 10235882
[No Abstract] [Full Text] [Related]
[Next] [New Search]
